Clinical trial
Safety and Acceptability Study of the UC-781 Microbicide Gel Applied Rectally
NCT00408538 · University of California, Los Angeles, Other · Completed
Key facts
| NCT number | NCT00408538 |
|---|---|
| Title | Safety and Acceptability Study of the UC-781 Microbicide Gel Applied Rectally |
| Official title | A Phase 1 Randomized, Blinded, Placebo-Controlled Safety and Acceptability Study of the UC-781 Vaginal Microbicide Gel Formulation Applied Rectally in HIV-1 Seronegative Adults |
| Lead sponsor | University of California, Los Angeles, Other |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH CONRAD |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | UC-781 microbicide gel (0.1% and 0.25%), placebo |
| Enrollment | 36 |
| Start date | Dec 1, 2006 |
| Completion | Apr 1, 2008 |
| First posted | Dec 7, 2006 |
| Last update posted | May 4, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: